Home/Filings/4/0000950170-24-116339
4//SEC Filing

Smeal Benjamin C. 4

Accession 0000950170-24-116339

CIK 0001403708other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 5:09 PM ET

Size

5.4 KB

Accession

0000950170-24-116339

Insider Transaction Report

Form 4
Period: 2024-10-18
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-10-18+5,8335,833 total
    Exercise: $5.51Exp: 2034-10-17Common Stock (5,833 underlying)
Footnotes (1)
  • [F1]1/3rd of the total number of shares of common stock subject to the option shall vest following each one-year period after October 18, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date, so that the option shall be fully vested on the third anniversary of the date of grant.

Documents

1 file

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1
  • filerCIK 0001748561

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 5:09 PM ET
Size
5.4 KB